baber/WOPTO huggingface dataset:
Patent NZ-575828-A (NZ)
Title: Solid of macrolide compound, method for production thereof, and pharmaceutical composition comprising the same
Inventor: ISHIHARA HIROSHI
IPC: A61K31/496
Filed: 2008-01-28
Abstract: Discloses is a solid form of a compound (8E,12E,14E)-7-{(4-cycloheptylpiperazin-1-yl)carbonyl}oxy-3,6,16,21-tetra-hydroxy-6,10,12,16,20-pentamethyl-18,19-epoxytricosa-8,12,14-trien-11-olide represented by formula (I) wherein the solid form is amorphous or crystalline. Further disclosed are processes for preparing said crystals of the compound represented by formula (I).
Patent NZ-578291-A (NZ)
Title: Obtaining discovery information, sending a request, receiving parameters, then executing multimedia using the parameters
Inventor: PETERSSON JUSTUS
IPC: H04L29/06
Filed: 2007-10-25
Abstract: Disclosed is a method and arrangement for remotely controlling the communication of media between devices in different local networks (200, 202) using a remote control device (200b). The remote control device (200b) obtains discovery information on a first device (200c) and sends a remote access request over a multimedia service network to a home multimedia gateway (202b) in the opposite local network (202) for a connection to a second device (202c) therein. The home multimedia gateway (202b) then responds with communication parameters established for the second device (202c) in a residential gateway, and the remote control device (200b) can then order the first device (200c) to execute a multimedia session with the second device (202c) by using the communication parameters. This solution enables a remote control device (200b) to visit a local network to order a device in that network to fetch media content from a device in another home network, or vice versa.
Patent NZ-581424-A (NZ)
Title: A thin cast strip product with microalloy additions, and method for making the same
Inventor: WILLIAMS JAMES GEOFFERY
IPC: B22D11/124
Filed: 2008-05-06
Abstract: Disclosed a steel product comprising, carbon, manganese, silicon, aluminum and niobium which has a majority of the microstructure comprised of bainite and acicular ferrite and has more than 70 percent niobium in solid solution. Also disclosed is a method of preparing the above steel product comprising: assembling internally a cooled roll caster having laterally positioned casting rolls forming a nip between them, and forming a casting pool of molten steel supported on the casting rolls above the nip and confined adjacent the ends of the casting rolls by side darns, counter rotating the casting rolls to solidify metal shells on the casting rolls as the casting rolls move through the casting pool, and forming steel strip from the metal shells cast downwardly through the nip between the casting rolls, and cooling the steel strip, wherein the steel strip has the majority of the microstructure comprised of bainite and acicular ferrite and having more than 70 precent of niobium in solid solution.
Patent NZ-582972-A (NZ)
Title: Rna sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles
Inventor: JURK MARION
IPC: C12N15/117
Filed: 2008-08-08
Abstract: Disclosed is a composition comprising a single-stranded immunostimulatory polymer selected from A-A-A-C-G-C-U-C-A-G-C-C-A-A-A-G-C-A-G; and A*A*A*C*G*C*U*C*A*G*C*C*A*A*A*G*C*A*G; and a delivery vehicle, wherein the delivery vehicle is a liposome, a noisome, a lipoplexe, a polyplexe, a lipopolyplexe, a water-in-oil emulsion, an oil-in-water emulsion, a water-in-oil-in water multiple emulsion, a micro-emulsion, a nano-emulsion, a micelle, a dendrimer, a virosome, a virus-like particle, a polymeric nanoparticle, or a polymeric microparticle and wherein the composition does not include lipofectin, and wherein "-" depicts a phosphodiester backbone and "*" depicts a phosphorothioate backbone. Also disclosed is the use of the composition in the manufacture of a medicament for treating an allergic condition, an infectious disease and cancer.
Patent NZ-584316-A (NZ)
Title: Method and Apparatus for Management of Multi-Carrier Communications in a Wireless Communication System
Inventor: BHUSHAN NAGA
IPC: H04J13/00
Filed: 2006-05-09
Abstract: A method for interleaving systematic bits and parity bits and generating an output sequence that can be transmitted in multi-slot packets from a base station to a remote station in a wireless communication system is disclosed. The method includes: demultiplexing the systematic bits and the parity bits into subpackets, so that the systematic bits and the parity bits are sequentially distributed among the subpackets; reordering the subpackets; forming matrices from the reordered subpackets based on an index set; permuting the matrices to form a juxtaposed matrix having segments, columns, and elements; interleaving the columns; modulating the elements in the segments; and truncating the modulated elements in the segments of the juxtaposed matrix. The output sequence includes truncated modulating elements from the segments of the juxtaposed matrix.
Patent NZ-586949-A (NZ)
Title: Lighting apparatus with circular upper plate and led modules on inner surface of inclined side portion.
Inventor: GILL JASON JAE
IPC: F21S8/08
Filed: 2008-03-21
Abstract: 586949 Disclosed is a lighting apparatus (10) using light emitting diodes (30). A lamp housing member has a circular upper plate and an inclined side portion formed at an outer circumference of the upper plate. Light emitting diode modules (12) are provided on an inner surface of the side portion. Inclined block members with one or more inclined planes (12a, 12b, 12c), are interposed between the side portion and the light emitting diode modules (12).
Patent NZ-590388-A (NZ)
Title: A sub-surface underwater anchor with a helical screw
Inventor: BAKER MICHAEL ARTHUR KEITH
IPC: E02D5/56
Filed: 2010-05-21
Abstract: Disclosed is a sub-surface ground anchor with means to minimise dirt build-up between the anchor and drive head connection. The anchor for subsurface installation in a ground surface includes an elongate tubular anchor body having an integrally formed tapered helical or screw anchoring feature around the anchor body for engaging with the ground. The integrally formed engagement protrusions extending outwardly from the anchor body of the anchor body engage with complementary engagement features of the drive head, which works the anchor into the ground. An outwardly extending flange comprises a tapered deflection surface that extends at an acute angle relative to the anchor body, and an abutment surface for contacting a lead surface of the drive head. The flange and engagement features being arranged such that when the engagement features of the anchor are engaged with the engagement features of the drive head, matter is inhibited from entering between the engagement features of the anchor and the engagement features of the drive head.
Patent NZ-592383-A (NZ)
Title: Pharmaceutical composition of a potent hcv inhibitor for oral administration
Inventor: CHEN FENG-JING
IPC: A61K9/08
Filed: 2009-11-18
Abstract: Disclosed is a liquid pharmaceutical composition which comprises: a.) 2 to 10 percent by weight of a potent hepatitis C viral inhibitor (Compound (1)), or a pharmaceutically acceptable salt thereof; b.) 10 to 30 percent by weight of at least one surfactant; and c.) 60 to 90 percent by weight of at least one pharmaceutically acceptable solvent; And wherein the composition is substantially free of lipid and forms a clear dispersion having a mean particle size of less than 1 micron upon dilution in simulated gastric fluid.
Patent NZ-592461-A (NZ)
Title: Rab6kifl/kif20a epitope peptide and vaccines containing the same
Inventor: NISHIMURA YASUHARU
IPC: A61P35/00
Filed: 2009-10-15
Abstract: Disclosed are oligopeptides comprising the amino acid sequence selected from the group consisting of SEQ ID NOs: 3, 4 and 5. The present invention also provides a pharmaceutical composition containing the amino acid sequence of selected from the group consisting of SEQ ID NOs: 3, 4 and 5 formulated for the treatment or prevention of cancer in a subject cia CTL incudement against cancer cells expressing RAB6KIFL and HLA-A2.
Patent NZ-593247-A (NZ)
Title: A pack for smoking articles having a plurality of protrusions on one of the major panels to space an outer wrapper from the surface
Inventor: BLAUDIN DE THE TANNEGUY
IPC: B65D85/10
Filed: 2009-11-19
Abstract: A pack for smoking articles (1) is disclosed having major front (2) and rear (3) planar panels and minor side panels (4, 5). At least one of the major panels (2) includes a plurality of discrete generally circular and convex protrusions spaced from each other and projecting outwardly. An outer wrapper is spaced from the surface of the panel(s) by the protrusions. A method of fabricating such a pack is also disclosed.
Patent NZ-594549-A (NZ)
Title: Allergen detection method using immunochromatography
Inventor: KATO SHIGEKI
IPC: G01N33/53
Filed: 2010-02-23
Abstract: Disclosed are allergens that can be extracted efficiently from a sample material, such as a food that contains the allergens, and the allergens can be detected quickly and precisely by eliminating the non-specific reactions accompanying the disintegration of colloidal gold bound to an antibody without using a reducing agent. A developing solution that contains at least 10% FBS is used with an immunochromatographic method that uses colloidal gold-labeled antibodies where colloidal gold is bound to monoclonal antibodies for denatured and native allergens, a development base to which is fixed monoclonal antibodies that recognize different epitopes than the colloidal gold-labeled antibodies, an allergen measurement sample extracted from the sample material using SDS or other anionic surfactant and a thiosulfate, or SDS or other anionic surfactant and Tween 20 or other non-ionic surfactant, and a developing solution, and that detects allergens according to whether or not there is a concentration of the colloidal gold after the developing solution is developed on the development base.
Patent NZ-595511-A (NZ)
Title: Encapsulated liver and erthropoietin cell composition for treatment of liver disease
Inventor: ALEKSANDROVA KRASIMIRA
IPC: A61P1/16
Filed: 2010-04-27
Abstract: Discloses microcapsules comprising a capsule shell encapsulating a suspension of liver cells or liver cell derivatives in physical contact to with an amount of erythropoietin capable of stimulating the liver cells. The size of the microcapsules is 100   700 mum. The amount of erythropoietin is in the range 10-7 to 10-2 U/ml of the cell suspension. Further disclosed are methods for production of the microcapsules. Further disclosed is the use of the microcapsules in the manufacture of a medicament for treatment of liver disease. The therapeutic application of the microcapsules is related to the provision of physiologically active cells for liver therapy or liver cell transplant technology.
Patent NZ-596595-A (NZ)
Title: Method for orthopoxvirus production and purification
Inventor: SENE CLAUDE
IPC: A61K38/18
Filed: 2010-05-11
Abstract: A method for producing and purifying a wild type, an attenuated and/or a recombinant Orthopoxvirus, comprising the following steps: a) preparing a culture of packaging cells; b) infecting the packaging cell culture with an Orthopoxvirus; c) culturing the infected packaging cells until progeny Orthopoxvirus is produced; d) incubation in presence of one or more nucleases; e) recovering the Orthopoxviruses from the culture supernatant and/or the packaging cells; f) adding monovalent salts to the Orthopoxviruses recovered in step e)under suitable conditions to inhibit the nuclease(s) activity and to avoid the adsorption of said Orthopoxviruses to the anion exchange adsorbent in step g); g) contacting the mixture obtained in step f) with an anion exchange adsorbent under suitable conditions to allow the capture of nucleic acids; h) clarifying the mixture obtained in step g) under suitable conditions to allow the withdrawal of the cellular debris; i) washing of the anion exchange adsorbent with a solution comprising monovalent salts under suitable conditions to recover the remained Orthopoxviruses in the flow through; j) concentrating the flow through obtained in step h) and the flow through obtained in step i); k) diafiltrating the fraction comprising the Orthopoxviruses obtained in step j).
Patent NZ-597109-A (NZ)
Title: Tablet composition having favorable dissolution property useful as an anticoagulant
Inventor: KOJIMA MASAZUMI
IPC: A61K47/26
Filed: 2008-03-28
Abstract: Disclosed is a pharmaceutical composition in tablet form comprising, as an active ingredient, N1-(5-chloropyridin-2-yl)-N2-((1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-{ [(5-methyl-4,5,6,7- tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino} cyclohexyl)ethanediamide, represented by formula (1), a pharmacologically acceptable salt thereof, or a hydrate of any of these, (B) at least one sugar alcohol selected from the group consisting of manitol, xylitol and erythritol, and (C) at least one water-swelling additive selected from the group consisting of pregelatinized starch and crystalline cellulose, wherein said pharmaceutical composition may be coated with at least one coating agent selected from among a cellulose derivative, a polyvinyl compound, an acrylate derivative, and saccharide, which may be selected from among hypromellose, methyl cellulose, ethyl cellulose, hydroxypropyl cellulose, polyvinyl alcohol, povidone, Polyvinyl acetate, polyvinyl acetal diethylaminoacetate, aminoalkyl methacrylate copolymer RS, ethyl acrylate-methyl methacrylate copolymer dispersion, sucrose, and mannitol.
Patent NZ-598575-A (NZ)
Title: Phosphonate compounds
Inventor: ALBERT DEVAUX
IPC: C07F9/38
Filed: 2007-12-11
Abstract: Abstract - 598575 Disclosed are phosphonate compound of the general formula: MO2C-X-N(U)-X-N(W)(ZPO3M2), wherein X is selected from a C2-C50 linear or branched hydrocarbon chain, or [A-O]x-A; wherein the linear or branched hydrocarbon chain of X can optionally be substituted by a linear or branched hydrocarbon group, which chain and/or which group can be optionally substituted by OH, COOH, F, OR' and SR' moieties; R' is a linear or branched hydrocarbon chain; A is a linear or branched hydrocarbon chain; x is an integer from 1 to 200; Z is a C1-C6 alkylene chain; M is selected from H and linear or branched hydrocarbon chains; W is selected from ZPO3M2 and [V-N(K)]nK, wherein V is selected from: a C2-C50 linear or branched hydrocarbon chain, or [A-O]x-A; wherein the linear or branched hydrocarbon chain of V can optionally be substituted by linear or branched hydrocarbon groups, which chains and/or groups are optionally substituted by OH, COOH, F, OR' or SR' moieties; K is ZPO3M2 or H; n is an integer from 0 to 200; U is selected from linear or branched C1-C12 hydrocarbon chains, H and X-N(W)(ZPO3M2). Also disclosed is a process for the manufacture of the phosphonate compounds as defined above by reacting a phosphonate having the formula: Y-X-N(W)(ZPO3M2) wherein Y is a suitable leaving group (the conjugated acid of which has a pKa equal to or smaller than 4), with a reaction partner MO2C-X-N(U)-H (including compounds such as caprolactam, 6-amino hexanoic acid, 2-pyrrolidone, 4-amino butanoic acid, lauryl lactam or 12-amino dodecanoic acid). Further disclosed is the use of a phosphonate compound as defined above as a dispersant, anionic surfactant, water treatment agent, scale inhibitor, pharmaceutical intermediate, detergent, secondary oil recovery agent, fertilizer or micronutrient.
Patent NZ-601095-A (NZ)
Title: Combined use of cry1ca and cry1ab proteins for insect resistance management
Inventor: MEADE THOMAS
IPC: C12N15/82
Filed: 2010-12-16
Abstract: Disclosed is a transgenic plant having transgenes encoding insecticidal proteins, wherein the insecticidal proteins are a Cry1C insecticidal protein, a Cry1Ab insecticidal protein and a Cry1Fa insecticidal protein. Also disclosed is a composition for controlling lepidopteran pests comprising non-human transgenic cells that express effective amounts of a Cry1Ab core toxin-containing protein, a Cry1C core toxin-containing protein and a Cry1Fa core toxin-containing protein, wherein said pests are selected from the group consisting of fall armyworm and sugarcane borer.
Patent NZ-601491-A (NZ)
Title: Method for mitigating on-path attacks in mobile ip network
Inventor: HADDAD WASSIM
IPC: H04L9/32
Filed: 2011-01-27
Abstract: 601491 A method performed by a mobile node (MN) of a mobile internet protocol (MIP) network to prevent an attacker on a path between a home agent (HA) associated with the MN and a correspondent node (CN) to hijack a session between the MN and the CN and a data processing system performing the method are disclosed. The data processing system comprises a processor; and a memory coupled to the processor for storing instructions, which when executed from the memory, cause the processor to transmit and receive first messages to and from a home agent (HA) and a correspondent node (CN) as part of participating in a first return routability procedure, including generating a first binding management key (Kbm), generate a first proof of knowledge (PoK) by hashing the first Kbm, transmit and receive second messages to and from the HA and the CN as part of participating in a second return routability procedure, including generating a second Kbm, generate a first binding update and binding acknowledgement (BU/BA) key by hashing the second Kbm and the first PoK, transmit a first binding update (BU) message to the CN with the first BU/BA key, wherein the first BU message is authenticated by the CN using the first BU/BA key that is independently derived by the CN, and in response to a first binding acknowledgement (BA) message received from the CN, authenticate the first BA message using the first BU/BA key, whereby the attacker is prevented from hijacking the session without possessing the first PoK.
Patent NZ-602343-A (NZ)
Title: Removal of selenium from refinery wastewater
Inventor: SHAH JITENDRA T
IPC: C02F1/52
Filed: 2011-03-09
Abstract: 602343 The disclosure provides a method of efficiently removing selenium from water particularly sour stripper water. The method involves: adding an oxidant to the aqueous solution, adjusting the aqueous solution's pH to below 7.5, adding ferric salt in an amount such that less than a quarter of selenium in the aqueous solution precipitates poly dithiocarbamate material (in ppm) is greater than the amount of ferric salt (in ppm). This method is alleged to remove far more selenium than previous methods, and to do so using a smaller amount of expensive chemicals. Moreover it is alleged this method makes it far more likely to achieve cost effective compliance with the ever-increasing environmental standards for selenium in water. Examples of acids that can be used to lower the pH include: sulfuric acid, HCL and H3PO4, examples of ferric salts that may be used include: ferric sulfate, ferric chloride, ferrous sulfate and ferrous chloride.
Patent NZ-604558-A (NZ)
Title: Deuterated benzylbenzene derivatives and methods of use
Inventor: XU MIN
IPC: C08K5/151
Filed: 2009-07-15
Abstract: 604558 Disclosed are deuterated compounds of formula (I) having an inhibitory effect on sodium-dependent glucose co-transporter SGLT. The invention also provides pharmaceutical compositions, methods of preparing the compounds, synthetic intermediates, and methods of using the compounds, independently or in combination with other therapeutic agents, for treating diseases and conditions that are affected by SGLT inhibition. Examples of compounds of formula (I) include deuterium substituted versions of: (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-hydroxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; (2S,3R,4R,5S,6R)-2-(4-chloro-3-((4-ethoxyphenyl)(hydroxy)methyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol and (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-(2-(2,2-difluoroethoxy)ethoxy)benzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol.
Patent NZ-614495-A (NZ)
Title: A system for detecting an animate intrusion into a vehicle
Inventor: BRENT LINDSAY BROWN
IPC: G08B21/18
Filed: 2013-08-20
Abstract: 614495 Disclosed is a system for reducing the risk of fire in a vehicle (1) by detection of a non-human animate intruder and/or foreign matter in an engine compartment and/or near an exhaust system. A sensor (2) remotely senses and the animate intruder and/or foreign matter in the engine compartment and/or near the exhaust system and sends the sensed data to a control module (3). Upon receiving the sensed data, the control module (3) switches a starter inhibiter (5) to an on mode which inhibits the engine or motor from starting.
Patent NZ-618682-A (NZ)
Title: Lysyl oxidase-like 2 assay and methods of use thereof
Inventor: SMITH VICTORIA
IPC: C07K16/40
Filed: 2012-06-01
Abstract: Disclosed are methods of detecting an active or advanced stage fibrotic disease comprising a) contacting a liquid sample with one or more lysyl oxidase-like 2 (LOXL2) specific antibodies; and b) detecting the presence of an anti-LOXL2 antibody/LOXL2 complex; wherein the detected level of the anti-LOXL2 antibody/LOXL2 complex compared with a reference level indicates an active fibrotic disease or an advanced stage fibrotic disease.
Patent NZ-622210-A (NZ)
Title: Plasminogen and plasmin variants
Inventor: ZWAAL RICHARD REINIER
IPC: C12N15/11
Filed: 2012-08-13
Abstract: Disclosed is an isolated plasminogen variant or plasmin variant obtained therefrom, or an isolated plasmin variant, wherein said variants are comprising an activation site and a catalytic domain, wherein said catalytic domain contains a mutation of the amino acid at position 1 of the human plasmin catalytic domain or at a position corresponding thereto in a non-human plasmin catalytic domain, wherein (i) the amino acid at position -1 relative to the plasmin catalytic domain is an arginine, lysine or other amino acid that maintains functionality of the activation site, (ii) the amino acid at position 24 of the human plasmin catalytic domain, or at the corresponding position of a non-human plasmin catalytic domain, is a methionine, and (iii) the amino acid at position 1 is mutated into an amino acid different from glycine or proline, and wherein said human plasmin catalytic domain is starting with the amino acid valine at position 1 which is the same valine amino acid occurring at position 562 of human Glu-plasminogen.
Patent NZ-703072-A (NZ)
Title: Preparation, uses and solid forms of obeticholic acid
Inventor: STEINER ANDRÉ
IPC: C07J51/00
Filed: 2013-06-17
Abstract: The present invention relates to obeticholic acid: or a pharmaceutically acceptable salt, solvate or amino acid conjugate thereof. Obeticholic acid is useful for the treatment or prevention of a FXR mediated disease or condition, cardiovascular disease or cholestatic liver disease, and for reducing HDL cholesterol, for lowering triglycerides in a mammal, or for inhibition of fibrosis. The present invention also relates to processes for the synthesis of obeticholic acid.